| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 12/06/2001 | WO2001091760A1 New use |
| 12/06/2001 | WO2001091754A1 Protein kinase inhibitors |
| 12/06/2001 | WO2001091750A1 Use of a celecoxib composition for fast pain relief |
| 12/06/2001 | WO2001091743A1 Patch containing 4-biphenylacetic acid |
| 12/06/2001 | WO2001091736A2 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic |
| 12/06/2001 | WO2001091729A1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/06/2001 | WO2001091722A2 Water-thin emulsions with low emulsifier levels |
| 12/06/2001 | WO2001091718A2 Occlusive transdermal therapeutic system wit a non-occlusive backing layer |
| 12/06/2001 | WO2001091682A1 Composition and applicator for topical substance delivery |
| 12/06/2001 | WO2001056532A3 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc) |
| 12/06/2001 | WO2001051474A3 Polypharmacophoric agents |
| 12/06/2001 | WO2001049673A3 Compounds and methods for modulation of estrogen receptors |
| 12/06/2001 | WO2001046392A3 Homologues of human heparanase and splice variants thereof |
| 12/06/2001 | WO2001034138B1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 12/06/2001 | WO2001032127A3 Method and compositions for treating pulmonary diseases |
| 12/06/2001 | WO2001025257A3 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 12/06/2001 | WO2001018042A3 Apoptosis proteins |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2001012662A3 Membrane associated proteins |
| 12/06/2001 | WO2001010847A8 Novel integrin receptor antagonists |
| 12/06/2001 | WO2000077018A3 Purine derivatives |
| 12/06/2001 | WO2000061750A3 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 12/06/2001 | US20010049377 Glucocortiocoid-selective antiinflammatory agents |
| 12/06/2001 | US20010049371 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases |
| 12/06/2001 | US20010049122 For reducing inflammation, for treating an autoimmune disease, for enhancing transplantation of tissue grafts, increasing antitumor immunity, and inhibiting viral and parasitic infections |
| 12/06/2001 | US20010049106 ADAM (A Disintegrin And Metalloprotease) family of metalloproteases, and in addition contain thrombospondin domain (TS); treating diabetes, arthritis, cancer, solid tumors, autoimmune diseases |
| 12/06/2001 | US20010048929 Novel multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 12/06/2001 | DE10027025A1 Clycinamide Clycinamide |
| 12/06/2001 | DE10027024A1 Carbaminsäureester Carbamic |
| 12/06/2001 | DE10026699A1 Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage Formulation of heparin, glycosaminoglycan or Heparinoidbasis and use of the formulation and the formulation base |
| 12/06/2001 | CA2736344A1 Tnf-.alpha. production inhibitors |
| 12/06/2001 | CA2617253A1 Synergistic agents for enhancing tissue repair |
| 12/06/2001 | CA2599562A1 Compounds for modulating the rage receptor |
| 12/06/2001 | CA2411655A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | CA2411323A1 Il-8 receptor antagonists |
| 12/06/2001 | CA2410734A1 Dnas encoding mammalian histamine receptor of the h4 subtype |
| 12/06/2001 | CA2410640A1 3-substituted isoquinolin-1-yl derivatives |
| 12/06/2001 | CA2410470A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | CA2410453A1 Neuroprotective peptides |
| 12/06/2001 | CA2410087A1 Mammalian protein phosphatases identified by in-silico analysis |
| 12/06/2001 | CA2410084A1 Transporters and ion channels |
| 12/06/2001 | CA2409927A1 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic |
| 12/06/2001 | CA2409617A1 2,7-naphthyridine derivatives |
| 12/06/2001 | CA2409597A1 Protein kinase inhibitors |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/06/2001 | CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/06/2001 | CA2408793A1 Use of a celecoxib composition for fast pain relief |
| 12/06/2001 | CA2406979A1 Indole derivatives with vascular damaging activity |
| 12/06/2001 | CA2383432A1 Therapeutic immune condition compositions and methods |
| 12/05/2001 | EP1160322A2 Human melanocyte stimulating hormone receptors |
| 12/05/2001 | EP1160255A1 Monovalent antibody fragments |
| 12/05/2001 | EP1160254A1 Human vanilloid receptor-like proteins |
| 12/05/2001 | EP1160240A1 Guanylhydrazones for treating inflammatory conditions |
| 12/05/2001 | EP1159962A1 Liposome preparations |
| 12/05/2001 | EP1159457A1 T cell receptor vbeta beta-jbeta) sequence and methods for its detection |
| 12/05/2001 | EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 12/05/2001 | EP1159418A2 Muc-1 antagonists and methods of treating immune disorders |
| 12/05/2001 | EP1159417A2 Polynucleotides and proteins encoded thereby |
| 12/05/2001 | EP1159300A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 12/05/2001 | EP1159291A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 12/05/2001 | EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta |
| 12/05/2001 | EP1159275A2 Imidazole compounds as histamine h3 ligands |
| 12/05/2001 | EP1159274A2 Method for the preparation of citalopram |
| 12/05/2001 | EP1159269A1 Anti-imflammatory indole derivatives |
| 12/05/2001 | EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors |
| 12/05/2001 | EP1159256A1 Sphingoid base derivatives and uses thereof |
| 12/05/2001 | EP1159009A2 Use of niaouli essential oil as transdermal permeation enhancer |
| 12/05/2001 | EP1159006A2 Water-soluble compositions of bioactive lipophilic compounds |
| 12/05/2001 | EP1158994A1 Pharmaceutical composition comprising mixed aqueous extract of anemarrhena rhizoma and phellodendron bark for analgesic and anti-inflammation |
| 12/05/2001 | EP1158988A2 Corticosteroid formulation |
| 12/05/2001 | EP1158986A1 Protease inhibitors |
| 12/05/2001 | EP1158970A1 Combinations of formoterol and a tiotropium salt |
| 12/05/2001 | EP1158967A1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix |
| 12/05/2001 | EP1146035A9 Crystal polymorphism of aminoethylphenoxyacetic acid derivative |
| 12/05/2001 | EP1017377B1 Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions |
| 12/05/2001 | EP0937036B1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 12/05/2001 | EP0835263B1 Somatostatin peptides |
| 12/05/2001 | EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors |
| 12/05/2001 | EP0814815A4 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 12/05/2001 | EP0779886B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 12/05/2001 | EP0751954B1 Anti-inflammatory composition and method with des-tyr dynorphin and analogues |
| 12/05/2001 | EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity |
| 12/05/2001 | EP0745071B1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity |
| 12/05/2001 | EP0720484B1 Plant material for controlling immune responses in mammals and method for producing the material |
| 12/05/2001 | EP0643701B1 Benzimidazole-derived compounds, method for preparing same, and therapeutical and cosmetic uses thereof |
| 12/05/2001 | EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
| 12/05/2001 | EP0445255B2 USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER |
| 12/05/2001 | CN1325393A Method for producing luteolin and luteolin derivatives |
| 12/05/2001 | CN1325299A Orally administered controlled drug delivery system providing temporal and spatial control |
| 12/05/2001 | CN1325291A Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 12/05/2001 | CN1324951A High-efficiency expression and application of human recombinant interferon B |
| 12/05/2001 | CN1324626A Mongolia medicine for treating pain of cervical vertebra, lumber vertebra and joints |
| 12/05/2001 | CN1324623A Rheumatism treating medicine powder |
| 12/05/2001 | CN1324616A Medicine for treating rheumatism and rheumatoid disease |
| 12/05/2001 | CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor |
| 12/05/2001 | CN1075812C Prodrugs of morpholine tachykinin receptor antagonists |
| 12/05/2001 | CN1075809C Novel vitamin D analogues |
| 12/05/2001 | CN1075730C Wind-dispelling meridian passage-dredging and pus-drawing out medicinal powder |
| 12/05/2001 | CN1075728C Antiphlogistic healing ointment for curing surgical infection |
| 12/04/2001 | US6326510 Skin disorders; anticancer agents |